REVIEW

Emerging roles of BRCA1 alternative splicing

T I Orban, E Olah

National Institute of Oncology, Department of Molecular Genetics, Budapest, H-1122, Hungary

Correspondence to:
Correspondence to:
T I Orban, National Institute of Oncology, Department of Molecular Genetics, Rath Gy. u. 7–9, Budapest, H-1122, Hungary;
orbi{at}oncol.hu

Germline mutations of the BRCA1 gene predispose individuals mainly to the development of breast and/or ovarian cancer. However, the exact function of the gene is still unclear, although the encoded proteins are involved in various cellular processes, including transcriptional regulation and DNA repair pathways. Several BRCA1 splice variants are found in different tissues, but in spite of intense investigations, their regulation and possible functions are poorly understood at the moment. This review summarises current knowledge on the roles of these splice variants and the mechanisms responsible for their formation. Because alternative splicing is now widely accepted as an important source of genetic diversity, elucidating the functions of the BRCA1 splice variants would help in the understanding of the exact role(s) of this tumour suppressor. This should help to resolve the current paradox that, despite its seemingly vital cellular functions, mutations of this gene are associated with tissue specific tumour formation predominantly in the breast and the ovary.

Keywords: BRCA1; alternative splicing; breast cancer; ovarian cancer

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Papp, L. V., Wang, J., Kennedy, D., Boucher, D., Zhang, Y., Gladyshev, V. N., Singh, R. N., Khanna, K. K. (2008). Functional characterization of alternatively spliced human SECISBP2 transcript variants. Nucleic Acids Res 36: 7192-7206 [Abstract] [Full Text]  
• DelloRusso, C., Welcsh, P. L., Wang, W., Garcia, R. L., King, M.-C., Swisher, E. M. (2007). Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation. Mol Cancer Res 5: 35-45 [Abstract] [Full Text]  
• Romero, P. R., Zaidi, S., Fang, Y. Y., Uversky, V. N., Radivojac, P., Oldfield, C. J., Cortese, M. S., Sickmeier, M., LeGall, T., Obradovic, Z., Dunker, A. K. (2006). Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. Proc. Natl. Acad. Sci. USA 103: 8390-8395 [Abstract] [Full Text]  
• Watermann, D. O., Tang, Y., zur Hausen, A., Jager, M., Stamm, S., Stickeler, E. (2006). Splicing Factor Tra2-{beta}1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of the CD44 Gene.. Cancer Res. 66: 4774-4780 [Abstract] [Full Text]  
• Chen, F.-C., Wang, S.-S., Chen, C.-J., Li, W.-H., Chuang, T.-J. (2006). Alternatively and Constitutively Spliced Exons Are Subject to Different Evolutionary Forces. Mol Biol Evol 23: 675-682 [Abstract] [Full Text]  
• Li, C., Kato, M., Shiue, L., Shively, J. E., Ares, M. Jr., Lin, R.-J. (2006). Cell Type and Culture Condition-Dependent Alternative Splicing in Human Breast Cancer Cells Revealed by Splicing-Sensitive Microarrays. Cancer Res. 66: 1990-1999 [Abstract] [Full Text]  
• Avellar, M. C. W., Honda, L., Hamil, K. G., Yenugu, S., Grossman, G., Petrusz, P., French, F. S., Hall, S. H. (2004). Differential Expression and Antibacterial Activity of Epididymis Protein 2 Isoforms in the Male Reproductive Tract of Human and Rhesus Monkey (Macaca mulatta). Biol. Reprod. 71: 1453-1460 [Abstract] [Full Text]